Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menggang Yu

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Journal of the American Medical Informatics Association : JAMIA|June 25, 2019
The importance of health insurance claims data in creating learning health systems: evaluating care for high-need high-cost patients using the National Patient-Centered Clinical Research Network (PCORNet)Maureen A Smith, Mary S Vaughan-Sarrazin, Menggang Yu, et al.
Plos One|June 26, 2015
Correction: differential CARM1 isoform expression in subcellular compartments and among malignant and benign breast tumorsDavid Shlensky, Jennifer A Mirrielees, Zibo Zhao, et al.
Head & Neck|July 25, 2017
Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer DatabaseHuaising C Ko, Shuai Chen, Aaron M Wieland, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 20, 2017
Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic LarynxHuaising C Ko, Paul M Harari, Shuai Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II studyShadia Jalal, Rafat Ansari, Ramaswamy Govindan, et al.
Otorhinolaryngology-Head and Neck Surgery|October 2, 2018
HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patientsAdam R Burr, Paul M Harari, Huaising C Ko, et al.
Clinical Lung Cancer|October 30, 2012
Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77Heather Riggs, Shadia I Jalal, Tareq Al Baghdadi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology GroupAnuj Agarwala, William Fisher, Daniel Bruetman, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 22, 2009
A new probabilistic rule for drug-dug interaction predictionJihao Zhou, Zhaohui Qin, Sara K Quinney, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 4, 2022
Clinical utility of a regional precision medicine molecular tumor board and challenges to implementationKeng Hee Peh, Daniel J Przybylski, Michael J Fallon, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Journal of the American Medical Informatics Association : JAMIA|June 25, 2019
The importance of health insurance claims data in creating learning health systems: evaluating care for high-need high-cost patients using the National Patient-Centered Clinical Research Network (PCORNet)Maureen A Smith, Mary S Vaughan-Sarrazin, Menggang Yu, et al.
Plos One|June 26, 2015
Correction: differential CARM1 isoform expression in subcellular compartments and among malignant and benign breast tumorsDavid Shlensky, Jennifer A Mirrielees, Zibo Zhao, et al.
Head & Neck|July 25, 2017
Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer DatabaseHuaising C Ko, Shuai Chen, Aaron M Wieland, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 20, 2017
Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic LarynxHuaising C Ko, Paul M Harari, Shuai Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II studyShadia Jalal, Rafat Ansari, Ramaswamy Govindan, et al.
Otorhinolaryngology-Head and Neck Surgery|October 2, 2018
HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patientsAdam R Burr, Paul M Harari, Huaising C Ko, et al.
Clinical Lung Cancer|October 30, 2012
Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77Heather Riggs, Shadia I Jalal, Tareq Al Baghdadi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology GroupAnuj Agarwala, William Fisher, Daniel Bruetman, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 22, 2009
A new probabilistic rule for drug-dug interaction predictionJihao Zhou, Zhaohui Qin, Sara K Quinney, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 4, 2022
Clinical utility of a regional precision medicine molecular tumor board and challenges to implementationKeng Hee Peh, Daniel J Przybylski, Michael J Fallon, et al.
Pageof 18